Vitamin D Supplementation May Be Beneficial for Long COVID

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

THURSDAY, March 12, 2026 -- Vitamin D3 supplementation does not change the four-week incidence of health care utilization or COVID-19-related outcomes among adults with newly diagnosed COVID-19 but may reduce the risk for long COVID, according to a study published online March 12 in the Journal of Nutrition.

Davaasambuu Ganmaa, M.D., Ph.D., from Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues examined the effect of vitamin D3 supplementation on health care utilization and other clinical outcomes among adults with COVID-19 in a parallel two-group randomized controlled trial. Adults with newly diagnosed COVID-19 were cluster-randomized with up to one of their cohabiting contacts to oral vitamin D3 supplementation (loading dose 9,600 IU/day for two days then 3,200 IU/day for four weeks) or placebo (863 and 884 participants, respectively).

The researchers observed no significant difference between the groups in the four-week cumulative incidence of health care utilization among index participants (cumulative incidences, 0.28 versus 0.29; odds ratio, 0.97; 95 percent confidence interval, 0.75 to 1.24). Prespecified secondary treatment and prevention outcomes also did not differ significantly. A nonsignificant trend toward benefit of vitamin D3 on the prevalence of long COVID at eight weeks was seen in per-protocol analyses (odds ratio, 0.78; 95 percent confidence interval, 0.59 to 1.03). There were no safety concerns noted.

"While we didn't find that high-dose vitamin D reduced COVID severity or hospitalizations, we observed a promising signal for long COVID that merits additional research," senior author JoAnn E. Manson, M.D., M.P.H., Dr.P.H., also from Brigham and Women's Hospital, said in a statement.

One author disclosed ties to Capitainer AB, a company commercializing the blood collection devices used in this study; support was provided by the Tishcon Corporation, Takeda, and Capitainer.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-03-13 08:47

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords